These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18508119)

  • 1. Dissociation of the anxiolytic-like effects of Avpr1a and Avpr1b receptor antagonists in the dorsal and ventral hippocampus.
    Engin E; Treit D
    Neuropeptides; 2008 Aug; 42(4):411-21. PubMed ID: 18508119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Α2 GABAA receptor sub-units in the ventral hippocampus and α5 GABAA receptor sub-units in the dorsal hippocampus mediate anxiety and fear memory.
    McEown K; Treit D
    Neuroscience; 2013 Nov; 252():169-77. PubMed ID: 23962649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors in the medial prefrontal cortex and hippocampus mediate rats' unconditioned fear behaviour.
    McEown K; Treit D
    Horm Behav; 2011 Nov; 60(5):581-8. PubMed ID: 21889941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT.
    Menard J; Treit D
    Behav Pharmacol; 1998 Mar; 9(2):93-101. PubMed ID: 10065929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats.
    Nascimento Häckl LP; Carobrez AP
    Neurobiol Learn Mem; 2007 Sep; 88(2):177-85. PubMed ID: 17540583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus.
    Engin E; Treit D
    Behav Pharmacol; 2007 Sep; 18(5-6):461-70. PubMed ID: 17762514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S; Tanoue A; Koshimizu TA; Kitagawa Y; Tsujimoto G
    Mol Pharmacol; 2004 Mar; 65(3):623-9. PubMed ID: 14978240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
    Santos CJ; Stern CA; Bertoglio LJ
    Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
    Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
    J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
    Serradeil-Le Gal C; Wagnon J; Simiand J; Griebel G; Lacour C; Guillon G; Barberis C; Brossard G; Soubrié P; Nisato D; Pascal M; Pruss R; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1122-30. PubMed ID: 11861823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
    Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
    Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the dorsal and ventral hippocampus in fear and memory of a shock-probe experience.
    McEown K; Treit D
    Brain Res; 2009 Jan; 1251():185-94. PubMed ID: 19061870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in intermale aggression are accompanied by opposite vasopressin release patterns within the septum in rats bred for low and high anxiety.
    Beiderbeck DI; Neumann ID; Veenema AH
    Eur J Neurosci; 2007 Dec; 26(12):3597-605. PubMed ID: 18052969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic-like effects of substance P administration into the dorsal, but not ventral, hippocampus and its influence on serotonin.
    Carvalho MC; Masson S; Brandão ML; de Souza Silva MA
    Peptides; 2008 Jul; 29(7):1191-200. PubMed ID: 18490080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.
    Bondi CO; Barrera G; Lapiz MD; Bedard T; Mahan A; Morilak DA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):482-95. PubMed ID: 17188790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
    Mak P; Broussard C; Vacy K; Broadbear JH
    J Psychopharmacol; 2012 Apr; 26(4):532-42. PubMed ID: 21890582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiogenic-like effects of mCPP microinfusions into the amygdala (but not dorsal or ventral hippocampus) in mice exposed to elevated plus-maze.
    Cornélio AM; Nunes-de-Souza RL
    Behav Brain Res; 2007 Mar; 178(1):82-9. PubMed ID: 17207863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours.
    Rostami P; Hajizadeh-Moghaddam A; Zarrindast MR
    Physiol Behav; 2006 May; 87(5):891-6. PubMed ID: 16600315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism of medial prefrontal cortex D4 receptors decreases fear-related behaviour in rats.
    Shah AA; Sjovold T; Treit D
    Eur J Neurosci; 2004 Jun; 19(12):3393-7. PubMed ID: 15217397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.